Metlife INC 8-K filings

MetLife Inc. announced robust second-quarter 2026 results, showcasing a 15% increase in adjusted earnings and a 20% rise in adjusted earnings per share, driven by favorable underwriting and volume growth.

MetLife, Inc. has disclosed preliminary variable investment income for the quarter ended June 30, 2026, estimating it to be between $220 million and $270 million pre-tax.

MetLife, Inc. announced robust first-quarter 2026 results, with net income up 30% and adjusted earnings up 18%, driven by strong performance across its business segments.

MetLife estimates first-quarter variable investment income between $475 million and $525 million, tracking ahead of its annual guidance pace.

MetLife, Inc. confirmed its first quarter 2026 dividend of $0.31501229 per share on its Series A preferred stock, payable March 16, 2026.

MetLife, Inc. successfully issued $1 billion in 5.850% fixed-to-fixed reset rate subordinated debentures maturing in 2056.

MetLife, Inc. announced the expansion of its Board of Directors and the immediate appointment of Daniel S. Glaser and Michelle R. Seitz as independent directors.

MetLife reported strong full-year and fourth-quarter 2025 results, surpassing key financial targets including adjusted EPS growth, free cash flow ratio, and direct expense ratio, while returning $4.4 billion to shareholders.

MetLife, Inc. announced a strategic reorganization, reclassifying MetLife Investment Management as a standalone reportable segment and adjusting other segment reporting retrospectively.

MetLife Investment Management has successfully closed its acquisition of PineBridge Investments, creating a combined entity managing $734.7 billion in assets.

MetLife, Inc. provided preliminary fourth-quarter and full-year 2025 financial estimates, including variable investment income and capital deployment plans, ahead of its official earnings release.

MetLife, Inc. announced the completion of its $10 billion variable annuity risk transfer transaction with Talcott Resolution Life Insurance Company, reducing portfolio risk.

MetLife, Inc. announced the declaration of quarterly dividends for its Series A, Series E, and Series F preferred stocks, payable December 15, 2025.

MetLife reports a robust third quarter 2025 with adjusted earnings up 15% and adjusted EPS ex. notable items rising 21%, driven by higher variable investment income and volume growth.

MetLife, Inc. filed a Certificate of Elimination to remove its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, from its charter after all shares were reacquired.

MetLife, Inc. anticipates its third-quarter 2025 variable investment income will meet its target of $425 million pre-tax, aligning with full-year guidance.

MetLife, Inc. advises shareholders against tendering shares in an unsolicited mini-tender offer by Potemkin Limited, citing a significantly below-market price.

MetLife, Inc. announced it will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, on September 15, 2025.

MetLife, Inc. announced the declaration of its third quarter 2025 preferred stock dividends, payable September 15, 2025.

MetLife reports a 16% drop in adjusted earnings for Q2 2025, primarily due to less favorable underwriting and lower investment margins, despite strong volume growth in international segments.

MetLife, Inc. announced the appointment of Adrienne O'Neill as Executive Vice President and Chief Accounting Officer, effective September 2, 2025, bringing extensive financial leadership experience from Manulife Financial Corporation.

MetLife, Inc. announced a strategic partnership with General Atlantic to launch Chariot Reinsurance, Ltd., which will reinsure approximately $10 billion of MetLife's structured settlement and group annuity contracts.

MetLife, Inc. has provided a preliminary, unaudited estimate of its variable investment income for the second quarter of 2025, projecting it to be between $175 million and $225 million pre-tax.

MetLife, Inc. announced that its common shareholders re-elected all eleven directors, ratified Deloitte & Touche LLP as the independent auditor for 2025, and approved executive compensation on an advisory basis at the annual meeting held on June 17, 2025.

MetLife, Inc. has completed a private placement of ¥87.84 billion in yen-denominated senior notes across six series with maturities ranging from 2032 to 2055, primarily to refinance existing debt and for general corporate use.

MetLife announces the declaration of quarterly dividends for its Series A, Series E, and Series F preferred stocks.

MetLife has reached an agreement with Talcott Resolution Life Insurance Company to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves.

MetLife's first quarter 2025 results show a 10% increase in net income, driven by strong performance in premiums, fees, and other revenues, as well as a new $3.0 billion share repurchase authorization.

David L. Herzog, a director of MetLife, Inc., has announced his resignation from the Board of Directors, effective May 1, 2025.

MetLife, Inc. has successfully issued $1 billion in 6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due in 2055, marking a significant financial transaction for the company.